IQVIA Holdings | IQV - Operating Expenses



IQVIA Holdings reported $3.46B in Operating Expenses for its fiscal quarter ending in June of 2025.


Operating Expenses Change Date
Accenture USD 14.75B 330.5M May/2025
Adcock Ingram Holdings ZAR 4.23B 196.72M Dec/2024
Agilent USD 1.38B 10M Jul/2025
Bruker USD 785.5M 15.9M Jun/2025
Cardinal Health USD 59.53B 5.38B Jun/2025
Celltrion KRW 718.99B 24.68B Jun/2025
Charles River Laboratories USD 899.8M 9.7M Jun/2025
Cigna USD 65.21B 1.72B Jun/2025
Cognizant Technology Solutions USD 4.43B 166M Jun/2025
Cspc Pharmaceutical CNY 5.22B 248.9M Mar/2025
CVS Health USD 96.53B 5.32B Jun/2025
Danaher USD 5.18B 718M Jun/2025
Dentsply International USD 825M 9M Jun/2025
Dianthus Therapeutics USD 35.12M 1.88M Jun/2025
Divis Laboratories Ltd 17.93B 130M Jun/2025
Elevance Health USD 47.14B 1.05B Jun/2025
Hologic USD 762.9M 249.4M Jun/2025
Humana USD 31.29B 1.19B Jun/2025
IBM USD 14.2B 812M Jun/2025
Illumina USD 845M 65M Jun/2025
Infosys INR 334.42B 10.92B Jun/2025
Kangmei Pharma CNY 1.25B 35.75M Jun/2025
Knight Therapeutics CAD 89.06M 2.02M Sep/2024
Laboratorios Farma EUR 132.33M 179.02M Jun/2025
Laboratory Of America USD 3.06B 51.8M Jun/2025
Malin Corporation EUR 1.1M 400K Dec/2024
McKesson USD 96.74B 7.51B Jun/2025
Mettler Toledo International USD 717.51M 35.71M Jun/2025
Organigram Holdings CAD 72.9M 18.86M Jun/2025
Pharma Mar EUR 32.29M 9.66M Jun/2025
Publicis EUR 3.67B 3.5B Jun/2025
Qiagen NV USD 397.57M 39.27M Jun/2025
Quest Diagnostics USD 2.32B 17M Jun/2025
Revvity USD 629.52M 36.99M Jun/2025
Sartorius EUR 722.5M 23.1M Jun/2025
Sino Biopharmaceutical CNY 11.66B 352.34M Dec/2024
Thermo Fisher Scientific USD 8.94B 291M Jun/2025
Tilray USD 253.17M 16.55M Nov/2024
UnitedHealth USD 106.47B 6B Jun/2025
Veeva Systems USD 562.55M 37.24M Jul/2025
Waters USD 583.12M 73.16M Jun/2025
Zz Pientze Pharmaceu 1.68B 272.39M Jun/2025